Hematopoietic Recovery after Anti-B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor T Cell Therapy (CAR T), Idecabtagene Vicleucel (Ide-cel), for Relapsed/ Refractory Multiple Myeloma (RRMM)
Year: 2023
Type: article
Authors: Razan Mohty, Dimitrios Drekolias, Lauren Peres, Ciara Freeman, Omar Castaneda, Rawan G Faramand, Laura Oswald, Kayla Reid, Gabe De Avila, Brandon Jamaal Blue, Ariel Grajales, Turab Mohammed, Jose Ochoa-Bayona, Alexandria M Shrewsbury, William Doyle, Rebecca Gonzalez, Jennifer Logue, Hany Elmariah, Michael D Jain, Hien Liu, Jason Brayer, Kenneth Shain, Rachid Baz, Melissa Alsina, Taiga Nishihori, Marco L. Davila, Frederick L. Locke, Doris K Hansen
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W4319263117